End Stage Liver Disease definition

End Stage Liver Disease means end stage liver failure as evidenced by all of the following:
End Stage Liver Disease means an irreversible chronic alteration of the hepatic parenchyma or the biliary ducal system resulting in a life threatening liver dysfunction. The above coverage is excluded if the etiology of the disease is due to chronic alcohol consumption or any self inflicted toxic or drug consumption.
End Stage Liver Disease means end

Examples of End Stage Liver Disease in a sentence

  • Model for End Stage Liver Disease (MELD)The scoring system used to measure illness severity in the allocation of livers to adults.

  • If at the conclusion of the transplant evaluation, the enrollee is listed with the United Network for Organ Sharing (UNOS) as a level 1A, 1B, or 2 candidate for a heart or lung transplant, or with a Model End Stage Liver Disease (MELD) score of 11-25 for a liver transplant, then the Health Plan must submit a copy of the UNOS form to BMHC with a request to disenroll the member from the Health Plan.

  • National and regional analysis of exceptions to the Pediatric End- Stage Liver Disease scoring system (2003–2004).

  • The ALFSG-PI was also significantly better than Model for End- Stage Liver Disease (MELD) score (0.70) or KCC (0.65).

  • End Stage Liver Disease means chronic end stage liver failure evidenced by all of the following:i.

  • Third, liver allocation policy is well suited to an analysis of manipulation because transplant priority is determined by a specific score—the Median End Stage Liver Disease (MELD) score.

  • In particular, we wanted to evaluate the association between preoperative Model for End- Stage Liver Disease (MELD), indocyanine green retention rates at 15 minutes (ICG15) and postoperative outcomes.A retrospective review of patients undergoing resection for hepatocellular carcinoma (HCC) was performed.

  • Development is in place for End Stage Liver Disease, COPD and periods in Diabetes.

  • We used the Child classification to define the underlying degree of liver dysfunction instead of the Model for End Stage Liver Disease (MELD) classification, mainly because it is more commonly used in this context.

  • CASE STUDY:NORTHERN NSW LOCAL HEALTH DISTRICTDrain the Pain - Liver Disease Treatment ProjectThe project aim was to implement a patient initiated admission process direct to the ward, to reduce the length of stay and improve end of life care planning for patients requiring large volume paracentesis secondary to End Stage Liver Disease (ESLD).The program was developed through extensive input from ESLD patients, carers and clinicians.


More Definitions of End Stage Liver Disease

End Stage Liver Disease means the end stage liver failure with increasing jaundice that in general medical opinion will not improve in future and resulting in either ascites or encephalopathy. Liver disease secondary to alcohol or drug abuse is excluded.

Related to End Stage Liver Disease

  • Massive Multiauthor Collaboration Site (or “MMC Site”) means any World Wide Web server that publishes copyrightable works and also provides prominent facilities for anybody to edit those works. A public wiki that anybody can edit is an example of such a server. A “Massive Multiauthor Collaboration” (or “MMC”) contained in the site means any set of copyrightable works thus published on the MMC site.

  • Phase III Trial means a Clinical Trial of an investigational product in subjects that incorporates accepted endpoints for confirmation of statistical significance of efficacy and safety with the aim to generate data and results that can be submitted to obtain Regulatory Approval as described in 21 C.F.R. 312.21(c), or a comparable Clinical Trial prescribed by the relevant Regulatory Authority in a country other than the United States.

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Non-surgically implanted prostheses means a replacement body part not surgically implanted.

  • Autism spectrum disorders means any of the pervasive developmental disorders as defined by the Diagnostic and Statistical Manual of Mental Disorders, 4th edition, published by the American Psychiatric Association, including autistic disorder, Asperger's disorder and pervasive developmental disorder not otherwise specified.

  • Autism spectrum disorder means a neuro-developmental condition typically appearing in the first three years of life that significantly affects a person's ability to communicate, understand relationships and relate to others, and is frequently associated with unusual or stereotypical rituals or behaviours.

  • POC means Point of Compliance. "POE" means Point of Exposure. "PSI" means pounds per square inch.

  • Substance use disorder professional means a person

  • Disease means an alteration in the state of the body or of some of its organs, interrupting or disturbing the performance of the functions, and causing or threatening pain and weakness or physical or mental disorder and certified by a Medical Practitioner.

  • inherited metabolic disease means a disease caused by an inherited abnormality of body chemistry for which testing is mandated by law;

  • sickle cell disease means a hemolytic disorder characterized by chronic anemia, painful events, and various complications due to associated tissue and organ damage; "hemolytic" refers to the destruction of the cell membrane of red blood cells resulting in the release of hemoglobin.

  • Health professional shortage area means that term as defined in section 332(a)(1) of subpart II of part C of title III of the public health service act, chapter 373, 90 Stat. 2270, 42 U.S.C. 254e.

  • MSAA Indicator Technical Specifications document means, as the context requires, either or both of the document entitled “Multi-Sector Service Accountability Agreement (MSAA) 2019-20 Indicator Technical Specifications November 5, 2018 Version 1.3” and the document entitled “Multi-Sector Service Accountability Agreement (MSAA) 2019-20 Target and Corridor-Setting Guidelines” as they may be amended or replaced from time to time;

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.

  • Cardiopulmonary resuscitation or "CPR" means artificial ventilation or external chest compression applied to a person who is unresponsive and not breathing.